Tue, Nov 25, 2014, 11:36 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Geron Corporation (GERN) Message Board

  • scistats scistats Dec 7, 2013 2:11 PM Flag

    A partnership is the only way to seal the Imetelstat deal for investors.

    It looks like the spleen data will be missing because at a least a few patients no longer have a spleen or did not have enlarged spleens when enrolled, despite having screened for advanced disease patients.

    Adam Feuerstein, who is not a medical professional is not qualified to judge Dr. Tefferi's interpretations, but he has everyone running in circles.

    Thinking rationally, the only way this juggernaut of spleens, lesions, complete, full, and partial recovery can be resolved from an investors standpoint is a solid partnership. Nothing says "it probably works" like a Pharmacyclics style agreement with the likes of a JNJ.

    If John A. Scarlett, M.D. cannot get a partnership in this favorable market environment with favorable Mayo data, it means either there is not enough data or imetelstat is not perceived as sufficiently effective to pursue.

    We await word of a partnership as a buyout would probably be too low of an offer.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
3.59-0.25(-6.51%)Nov 25 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.